Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 2 pseudogene 27 (HMGN2P27)
- Target
- HMGN2P27
- Molecular classification
- Pseudogene, non-coding RNA
01
Overview
High mobility group nucleosomal binding domain 2 pseudogene 27 (HMGN2P27) is a classified pseudogene in humans, derived from the high mobility group nucleosomal binding domain 2 gene through evolutionary duplication or processing[3][1][4]. Pseudogenes typically do not code for active proteins, but can participate in genomic regulation (e.g., by acting as a ceRNA). No specific functional activity, biological process, or disease association has been documented for HMGN2P27. It is not recognized as a functional receptor, enzyme, or pharmacological target in scientific or therapeutic literature, and no drugs or biomarkers are assigned to this pseudogene[4][3][5].
- Other names
- HMGN2P27
02
Mechanism of action
None. No mechanisms of drug action described for this pseudogene.
03
Biological functions
Competitive endogenous RNA (ceRNA): Some pseudogenes have been found to regulate parental gene expression via miRNA competition (miRNA decoy), though specific activity of HMGN2P27 has not been described for any particular miRNAGenomic regulation: Pseudogenes may impact gene expression in general, but specific biological functions for HMGN2P27 are not documented
04
Disease associations
None specifically documented for HMGN2P27. Other high mobility group pseudogenes have shown roles in certain cancers and metabolic regulation, but HMGN2P27 itself has not been implicated
Beyond the preview
Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 27 (HMGN2P27).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 27 (HMGN2P27).